| 000 | 00913 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517193058.0 | ||
| 264 | 0 | _c20190702 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/WNL.0000000000004869 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuerrini, Renzo | |
| 245 | 0 | 0 |
_aGenetic testing to prevent adverse reactions to antiepileptic drugs: Primum non nocere. _h[electronic resource] |
| 260 |
_bNeurology _c01 2018 |
||
| 300 |
_a155-156 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aAnticonvulsants |
| 650 | 0 | 4 | _aExanthema |
| 650 | 0 | 4 | _aGenetic Testing |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPhenytoin |
| 700 | 1 | _aPerucca, Emilio | |
| 773 | 0 |
_tNeurology _gvol. 90 _gno. 4 _gp. 155-156 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0000000000004869 _zAvailable from publisher's website |
| 999 |
_c27935344 _d27935344 |
||